J Med Life Sci > Volume 10(2); 2013 > Article
Journal of Medicine and Life Science 2013;10(2):179-183.
DOI: https://doi.org/10.22730/jmls.2013.10.2.179    Published online December 18, 2018.
Anti-proliferative Activity of NVP-BEZ235, a Dual Inhibitor of PI3K and mTOR, in Colorectal Cancer Cells
Deok Bae Park, Youngki Lee
Correspondence:  Youngki Lee,
Abstract
In colorectal cancer diverse mutations of genes involved in signal transduction pathways for cell survival and proliferation are observed, which have been the therapeutic targets for improvement of malignancies. The present study was undertaken to investigate whether NVP-BEZ235 (BEZ235), a dual inhibitor of PI3K/mTOR, shows any anti-proliferative effect on colorectal cell lines harboring KRAS, and/or, PIK3CA, and/or BRAF mutations and to determine whether these mutational status affects the sensitivity of colorectal cancer cells to BEZ235. BEZ235 treatment induced growth inhibition in all four cell lines tested. HCT116 cell line with both KRAS and PIK3CA mutation, and LoVo cell line with KRAS mutation showed higher IC50 values (643±19 nM and 663±7 nM, respectively) at 3 days post-treatment. On the other hand, HCT15 cell line harboring the same mutational status as HCT116 with KRAS and PIK3CA mutation, and HT29 cell line with BRAF mutation were more sensitive to BEZ235 (IC50 values; 25±7 nM and 213±40 nM, respectively). At suboptimal concentrations of BEZ235 (50 nM), HCT116 and LoVo cell lines were less responsive comparing with the HCT15 and HT29 cell lines, whereas a higher doses of BEZ235 showed a similar response of growth inhibition in all four cell lines tested except HCT15. These studies provide the preclinical rationale for evaluating the efficacy of BEZ235.
Key Words: NVP-BEZ235, PI3K, MTOR, KRAS, BRAF, colorectal cancer
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 2,075 View
  • 1 Download
Related articles


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
102, Jejudaehak-ro, Jeju-si, Jeju-do 63243, Republic of Korea
Tel: +82-64-754-8023    E-mail: jmls.jeju@gmail.com                

Copyright © 2024 by Jeju National University Institute for Medical Science.

Developed in M2PI

Close layer
prev next